Richard Bogan to Aged
This is a "connection" page, showing publications Richard Bogan has written about Aged.
Connection Strength
0.605
-
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022 01; 21(1):53-65.
Score: 0.065
-
Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep. 2021 03 12; 44(3).
Score: 0.061
-
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial. Ann Am Thorac Soc. 2020 08; 17(8):998-1007.
Score: 0.058
-
Demographic and nap-related variance of the MSLT: results from 2,498 suspected hypersomnia patients: Clinical MSLT variance. Sleep Med. 2019 03; 55:115-123.
Score: 0.052
-
Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations. Postgrad Med. 2017 Sep; 129(7):667-675.
Score: 0.048
-
Underutilization of the MSLT in sleepy patients with a short onset REM period (SOREMP) in the sleep clinic. Sleep Med. 2017 Apr; 32:150-156.
Score: 0.046
-
Who is getting tested for obstructive sleep apnea using a portable recording system? Test results from 193,221 patients. J Clin Sleep Med. 2014 Nov 15; 10(11):1193-8.
Score: 0.039
-
Sleep disordered breathing analysis in a general population using standard pulse oximeter signals. Sleep Breath. 2013 Sep; 17(3):1109-15.
Score: 0.035
-
Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clin Proc. 2010 Jun; 85(6):512-21.
Score: 0.029
-
Lack of impairment in glucose tolerance: support for further investigation of sleep restriction in older long sleepers. J Sleep Res. 2010 Mar; 19(1 Pt 1):116-7.
Score: 0.028
-
Weight loss in narcolepsy patients treated with sodium oxybate. Sleep Med. 2009 Jun; 10(6):661-3.
Score: 0.026
-
Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006 Jan; 81(1):17-27.
Score: 0.021
-
Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. J Neuropsychiatry Clin Neurosci. 2005; 17(3):405-12.
Score: 0.020
-
Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS. Sleep Med. 2019 02; 54:94-100.
Score: 0.013
-
Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families. Sleep Med. 2019 01; 53:88-93.
Score: 0.013
-
The National Veteran Sleep Disorder Study: Descriptive Epidemiology and Secular Trends, 2000-2010. Sleep. 2016 Jul 01; 39(7):1399-410.
Score: 0.011
-
Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Mov Disord. 2011 Sep; 26(11):2065-72.
Score: 0.008
-
Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010 Aug 15; 25(11):1675-83.
Score: 0.007
-
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc. 2010 Jul; 85(7):630-8.
Score: 0.007
-
Tolerance of chronic 90-minute time-in-bed restriction in older long sleepers. Sleep. 2009 Nov; 32(11):1467-79.
Score: 0.007
-
No effect of 8-week time in bed restriction on glucose tolerance in older long sleepers. J Sleep Res. 2008 Dec; 17(4):412-9.
Score: 0.006
-
Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clin Neuropharmacol. 2003 Sep-Oct; 26(5):252-7.
Score: 0.005